Share Twitter LinkedIn Facebook Email Amer Zeidan, MBBS Assistant Professor of Medicine (Hematology) at Yale University Discusses Is Patient Survival Based On Physician Experience At The 60th ASH Annual Meeting on Dec 1, 2018.
Inotuzumab Ozogamicin and Gemtuzumab Ozogamicin: A 2024 Guide to Managing Liver Toxicity and Cancer Treatment for Oncologists [40 Slides] Hematologic Malignancies 5 Mins Read
Non-Malignant Hematology Clinics: Essential Pioneers in the Evolving Hematologic Care Hematologic Malignancies 3 Mins Read
Spotlight on CAR T-cell Therapy in 2024: Advances & Clinical Insights Acute Lymphoblastic Leukemia 3 Mins Read